L Bardossy
Overview
Explore the profile of L Bardossy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brutzki T, Kulczycky M, Bardossy L, Clarke B, Blajchman M
Hematol J
. 2002 Mar;
2(3):188-95.
PMID: 11920244
Introduction: Disseminated intravascular coagulation in humans is frequently associated with Gram-negative bacterial sepsis. Therefore, to examine the role and time frame of the in vivo induction of tissue factor (TF)...
2.
Lee D, Bardossy L, Peterson N, Blajchman M
Blood
. 2000 Nov;
96(10):3630-6.
PMID: 11071664
Several different preparations of cross-linked hemoglobin (CLHb) are being evaluated for their efficacy and safety as red cell substitutes in a variety of preclinical and clinical settings. Because CLHb is...
3.
Hatton M, Ross B, Bardossy L, Southward S, Dereske M, Richardson M, et al.
Thromb Haemost
. 1999 Dec;
82(6):1694-702.
PMID: 10613657
During their growth, many malignant solid tumors elicit a hemostatic response in the host. In this report, the fluxes of various rabbit plasma hemostatic proteins into pulmonary VX-2 tumors have...
4.
Bardossy L, Robinson R, Ben-Hur E, Horowitz B, Blajchman M
Transfusion
. 1997 Oct;
37(9):889-95.
PMID: 9308633
Background: Treatment of platelet concentrates (PCs) with psoralens and broad-band ultraviolet A (UVA) radiation is being examined for the elimination of pathogens that might be present in donated blood. Previous...
5.
Moraes-Souza H, Bordin J, Bardossy L, Blajchman M
Rev Soc Bras Med Trop
. 1996 Jan;
29(1):47-9.
PMID: 8851215
The present measures adopted to prevent transfusion-associated Chagas' disease include screening of blood donors, and/or the inactivation of T. cruzi in collected blood using gentian violet (GV), as a trypanocidal...
6.
Moraes-Souza H, Bordin J, Bardossy L, MacPherson D, Blajchman M
Transfusion
. 1995 Sep;
35(9):723-6.
PMID: 7570930
Background: Transfusion-associated Chagas' disease (TA-CD) is a worldwide problem. Measures adopted to prevent TA-CD include the clinical and serologic screening of blood donors and/or the inactivation of Trypanosoma cruzi present...
7.
Bordin J, Bardossy L, Blajchman M
Blood
. 1994 Jul;
84(1):344-8.
PMID: 8018929
We had reported previously (Blood 81:1880, 1993) that allogeneic blood transfusions (ABT) administered before the infusion of tumor cells in both inbred and outbred experimental animals promote tumor growth and...
8.
Moraes-Souza H, Bordin J, Bardossy L, Blajchman M
Rev Soc Bras Med Trop
. 1994 Jul;
27(3):175.
PMID: 7972948
No abstract available.
9.
Blajchman M, Bordin J, Bardossy L, Heddle N
Br J Haematol
. 1994 Feb;
86(2):347-50.
PMID: 8199025
Clinical studies in anaemic uraemic patients have shown that increasing the haematocrit with either red blood cell (RBC) transfusions or erythropoietin corrects the prolonged bleeding time (BT) often seen in...
10.
Ali A, Warkentin T, Bardossy L, Goldsmith C, Blajchman M
Transfusion
. 1994 Jan;
34(1):44-7.
PMID: 8273128
Background: Platelet concentrates prepared from whole blood are generally suspended in a standard volume of 50 to 60 mL of plasma and can be stored thus at 20 to 24...